Inventage Lab (XKRX:389470) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Inventage Lab's Free Cash Flow for the three months ended in Mar. 2024 was ₩0.0 Mil. Inventage Lab's Revenue for the three months ended in Mar. 2024 was ₩96.9 Mil. Therefore, Inventage Lab's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Inventage Lab's current FCF Yield % is -22.71%.

The historical rank and industry rank for Inventage Lab's FCF Margin % or its related term are showing as below:

XKRX:389470' s FCF Margin % Range Over the Past 10 Years
Min: -2864.4 Med: -824.78 Max: -192.52
Current: -2668.88

During the past 5 years, the highest FCF Margin % of Inventage Lab was -192.52%. The lowest was -2864.40%. And the median was -824.78%.

XKRX:389470's FCF Margin % is ranked worse than
97.67% of 1029 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs XKRX:389470: -2668.88

Inventage Lab FCF Margin % Historical Data

The historical data trend for Inventage Lab's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab FCF Margin % Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-1,058.19

-591.37

-192.52

-2,864.40

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial					-8,221.24	-3,134.99	-11,197.40	-1,031.99	-

Competitive Comparison of Inventage Lab's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Inventage Lab's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inventage Lab's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inventage Lab's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Inventage Lab's FCF Margin % falls into.

Inventage Lab FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Inventage Lab's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-18852.125	/	658.152
	=	-2,864.40 %

Inventage Lab's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	96.928
	=	0.00 %

Inventage Lab FCF Margin % Related Terms

Thank you for viewing the detailed overview of Inventage Lab's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines